GLP-1 analogues, including Wegovy, Ozempic, Rybelsus, Retatrutide, and Tirzepatide, present diverse choices for individuals seeking effective weight management solutions
closer ophthalmic monitoring is advisable in this group, consistent with NICE guidance on type 2 diabetes management Individuals with renal impairment or those prone to volume depletion : Significant gastrointestinal losses increase the risk of AKI
GLP-1 agonists, by design, improve gut function creating a positive cascade that supports clearer thinking and emotional regulation
Human dosing strategies are still being refined
Remember: you have to eat even if you are on a GLP-1 like Zepbound, Wegovy, Ozempic, or Mounjaro
Many patients prefer pills to needles, she said